At a glance
- What the study gets you
- Health checks and monitoring — no treatment given
- Type of study
- Observational (no treatment given)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- Not specified by the sponsor
- How long the study runs
- Study runs about 87 months (dates as stated)
- About the drug or intervention
- Not specified by the sponsor
- Patient visit burden
- Not specified by the sponsor
- Type of study
- Observing health over time
- Ages
- 18 Years and over
- Who
- All
- Number of participants
- 1,183
- Started
- 2018-04-15
- Last checked
- 2026-07
Plain English Summary
What is this study?
- • Testing a new treatment for asthma
- • Clinical study - 1,183 participants
- • The Salford Lung Study (SLS) subjects represent a group of COPD and asthma patients whose disease is extremely well-characterised over a short time period
Who can take part?
- • Ages 18 Years and over
- • Diagnosed with asthma
Where?
- • Manchester - GSK Investigational Site
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
The Salford Lung Study (SLS) subjects represent a group of COPD and asthma patients whose disease is extremely well-characterised over a short time period. Subjects in the SLS originally consented for information relevant to the study to be shared with the sponsor (GSK). These data were limited to three years prior to randomisation and the twelve-month interventional treatment period. Broadened access to patients' data would allow SLS subjects' entire disease journey to be researched, presenting a rare opportunity to improve scientific and clinical understanding of COPD/asthma disease risk, treatment and progression. This proposal seeks to collect additional subject-level data from SLS patients via their electronic medical records (encompassing past and future data for up to 10 years from the date of consent) and via a one-off patient questionnaire administered at the time of consent.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 18 Years and over
- Who can join: All genders
What the study is looking for
- ✓Subjects who were randomly assigned to treatment in the original SLS studies
- ✓Subjects who are able to, and choose to, provide written consent for the additional information to be collected.
Who cannot take part
- ✗Subjects who were lost to follow-up/moved away, withdrew consent or died during or subsequent to the original SLS...
- ✗Subjects considered (at the discretion of the investigator) as too ill to participate or without the mental capacity...
See the full criteria
Where Is This Study? (1 UK site)
GSK Investigational Site
Manchester M274AF, United Kingdom